- $74.50m
- $67.60m
- $0.13m
Brief: Predictive Oncology Announces New CEO Raymond F. Vennare
Brief: Predictive Oncology Announces CEO Retirement
Brief: Predictive Oncology Reports Second Quarter 2022 Financial Results
Brief: Predictive Oncology Announces $7.2 Million Registered Direct Offerings
Brief: Predictive Oncology- Got Letter From Staff Of Nasdaq That Co Is Not In Compliance With The Minimum Bid Price Requirement For Continued Listing
Brief: Predictive Oncology Reports First Quarter Financial Results
Predictive Oncology Inc expected to post a loss of 4 cents a share - Earnings Preview
Predictive Oncology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Predictive Oncology Says On March 31, Nasdaq Notified Co That It Determined That Co Has Regained Compliance With Nasdaq Listing Rule
Predictive Oncology Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Predictive Oncology Validates Discovery 21 Proof-Of-Concept Campaign
Predictive Oncology Inc expected to post a loss of 2cents a share - Earnings Preview
Predictive Oncology Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Predictive Oncology Inc - Received A Letter From Listing Qualifications Department Of Nasdaq Stock Market
Brief: Predictive Oncology Acquires Zpredicta, Inc.
Brief: Predictive Oncology - As Part Of Deal, Interests, Stock Holders, Of Unit, Prior To Deal, Collectively Got Consideration Of About $10.0 Million In Cash
Predictive Oncology Inc reports results for the quarter ended in September - Earnings Summary
Brief: Predictive Oncology Posts Q3 Loss Per Share Of $0.08
Predictive Oncology Inc reports results for the quarter ended in June - Earnings Summary